Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of VYNDAQEL® (tafamidis), a once-daily 61 mg oral capsule, for the...
What’s the story of the first vaccine? How have vaccines affected us? And how do they work? Introducing The Antigen, our first 8-part podcast, focusing on the global impact of vaccines.